Myovant Sciences Ltd.
MYOVDelisted Mar 10, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001679082
Myovant Sciences Ltd. was delisted on Mar 10, 2023; its insiders filed their last Form 4 on Mar 10, 2023; 118 institutions reported holding it in 13F filings for Q4 2022, worth $1.12B in total; no superinvestor held it.
13F holders, Q3 2021
Institutional positions in Myovant Sciences Ltd. as of Sep 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 105
- −2 vs. Q2 2021
- Shares held
- 30.2M
- −2.15M (−6.7%) vs. Q2 2021
- Total value
- $677.6M
- −$59.0M (−8.0%) vs. Q2 2021
- New holders
- 14
- 34 more added
- Sold out
- 16
- 37 more reduced
1 institution that held it in Q2 2021 haven't filed for Q3 2021 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting MYOV on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 1 | $27 |
| Q1 2026 | 1 | $27 |
| Q4 2025 | 1 | $27 |
| Q3 2025 | 1 | $27 |
| Q2 2025 | 1 | $27 |
| Q1 2025 | 1 | $27 |
| Q4 2024 | 1 | $27 |
| Q3 2024 | 1 | $27 |
| Q2 2024 | 1 | $27 |
| Q1 2024 | 1 | $27 |
| Q4 2023 | 1 | $27 |
| Q3 2023 | 1 | $27 |
| Q2 2023 | 1 | $27 |
| Q1 2023 | 2 | $27 |
| Q4 2022 | 118 | $1.12B |
| Q3 2022 | 98 | $511.5M |
| Q2 2022 | 91 | $369.3M |
| Q1 2022 | 89 | $400.0M |
| Q4 2021 | 110 | $475.6M |
| Q3 2021 | 105 | $677.6M |
| Q2 2021 | 108 | $736.6M |
| Q1 2021 | 104 | $623.2M |
Institutions, Q3 2021
Shares, value and share of portfolio for each institution holding Myovant Sciences Ltd.; share changes are against Q2 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Norges Bank | 1,271,756 | $28.5M | 0.01% | +11,086+0.9% | Added |
| State Street Corp | 2,285,859 | $51.3M | 0.00% | −8,958−0.4% | Reduced |
| Janus Henderson Group PLC | 5,679,050 | $127.4M | 0.06% | +258,033+4.8% | Added |
| Bellevue Group AG | 5,769,039 | $129.5M | 1.31% | +500,000+9.5% | Added |
| Wellington Management Group LLP | 6,694,879 | $150.2M | 0.03% | +172,805+2.6% | Added |
| PFM Health Sciences, LP | 0 | $0 | 0.00% | −1,912,188−100.0% | Sold out |
| Schroder Investment Management Group | 0 | $0 | 0.00% | −246,528−100.0% | Sold out |
| Marshall Wace North America L.P. | 0 | $0 | 0.00% | −192,994−100.0% | Sold out |
| Point72 Asset Management, L.P. | 0 | $0 | 0.00% | −154,800−100.0% | Sold out |
| Raymond James & Associates | 0 | $0 | 0.00% | −75,086−100.0% | Sold out |
| Arrowstreet Capital, Limited Partnership | 0 | $0 | 0.00% | −69,800−100.0% | Sold out |
| Nuveen Asset Management, LLC | 0 | $0 | 0.00% | −65,856−100.0% | Sold out |
| Marshall Wace, LLP | 0 | $0 | 0.00% | −25,814−100.0% | Sold out |
| Invesco Ltd. | 0 | $0 | 0.00% | −23,690−100.0% | Sold out |
| Engineers Gate Manager LP | 0 | $0 | 0.00% | −20,270−100.0% | Sold out |
| Trexquant Investment LP | 0 | $0 | 0.00% | −17,466−100.0% | Sold out |
| Verition Fund Management LLC | 0 | $0 | 0.00% | −15,241−100.0% | Sold out |
| Pinz Capital Management, LP | 0 | $0 | 0.00% | −5,500−100.0% | Sold out |
| Advisory Services Network, LLC | 0 | $0 | 0.00% | −2,650−100.0% | Sold out |
| Lindbrook Capital, LLC | 0 | $0 | 0.00% | −1,000−100.0% | Sold out |
| Community Bank, N.A. | 0 | $0 | 0.00% | −500−100.0% | Sold out |
| CWM, LLC | – | – | – | – | Not filed |